{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:04:19Z","timestamp":1792760659310,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.thromres.2023.01.012","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T11:05:45Z","timestamp":1673867145000},"page":"102-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Platelet function and soluble P-selectin in patients with primary immune thrombocytopenia"],"prefix":"10.1016","volume":"223","author":[{"given":"Dino","family":"Mehic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Machacek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisbeth","family":"Buresch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Kaider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Eichelberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmuth","family":"Haslacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fillitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Dixer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Flasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Anderle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Assinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cihan","family":"Ay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Pabinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Gebhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2023.01.012_bb0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1172\/JCI113060","article-title":"Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance","volume":"80","author":"Ballem","year":"1987","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2023.01.012_bb0010","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1182\/blood-2009-01-129155","article-title":"The ITP syndrome: pathogenic and clinical diversity","volume":"113","author":"Cines","year":"2009","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2023.01.012_bb0015","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.3390\/jcm6020016","article-title":"Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP)","volume":"6","author":"Zufferey","year":"2017","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.thromres.2023.01.012_bb0020","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2023.01.012_bb0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/tmrv.2002.29403","article-title":"Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions","volume":"16","author":"Friedmann","year":"2002","journal-title":"Transfus. Med. Rev."},{"key":"10.1016\/j.thromres.2023.01.012_bb0030","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1182\/blood-2009-04-215525","article-title":"Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases","volume":"114","author":"Psaila","year":"2009","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2023.01.012_bb0035","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1056\/NEJMoa0904084","article-title":"Dose of prophylactic platelet transfusions and prevention of hemorrhage","volume":"362","author":"Slichter","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2023.01.012_bb0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00508-012-0123-3","article-title":"Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (\u00d6GHO)","volume":"124","author":"Pabinger","year":"2012","journal-title":"Wien. Klin. Wochenschr."},{"key":"10.1016\/j.thromres.2023.01.012_bb0045","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2141.2010.08418.x","article-title":"Risk of venous thromboembolism in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study","volume":"152","author":"Severinsen","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2023.01.012_bb0050","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3324\/haematol.2009.018390","article-title":"Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database","volume":"95","author":"Sarpatwari","year":"2010","journal-title":"Haematologica."},{"key":"10.1016\/j.thromres.2023.01.012_bb0055","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/bloodadvances.2017007989","article-title":"ITP and thrombosis: an intriguing association","volume":"1","author":"Rodeghiero","year":"2017","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2023.01.012_bb0060","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.hoc.2013.03.001","article-title":"Immune thrombocytopenia","volume":"27","author":"Kistangari","year":"2013","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.thromres.2023.01.012_bb0065","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1172\/JCI106064","article-title":"Heterogeneity of human platelets","volume":"48","author":"Karpatkin","year":"1969","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2023.01.012_bb0070","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/blood.V51.2.307.307","article-title":"Heterogeneity of human platelets. VI. Correlation of platelet function with platelet volume","volume":"51","author":"Karpatkin","year":"1978","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2023.01.012_bb0075","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1600-0609.2007.00900.x","article-title":"Agonist-inducible platelet activation in chronic idiopathic autoimmune thrombocytopenia","volume":"79","author":"Panzer","year":"2007","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.thromres.2023.01.012_bb0080","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1182\/blood-2013-08-519686","article-title":"Functional platelet defects in children with severe chronic ITP as tested with 2 novel assays applicable for low platelet counts","volume":"123","author":"van Bladel","year":"2014","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2023.01.012_bb0085","first-page":"549","article-title":"Platelet function in adult ITP patients can be either increased or decreased, compared to healthy controls, and is associated with bleeding risk","volume":"21","author":"Middelburg","year":"2016","journal-title":"Hematol. Amst. Neth."},{"key":"10.1016\/j.thromres.2023.01.012_bb0090","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/pbc.21000","article-title":"Flow cytometric evaluation of platelet activation in chronic autoimmune thrombocytopenia","volume":"47","author":"Panzer","year":"2006","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.thromres.2023.01.012_bb0095","doi-asserted-by":"crossref","first-page":"11107","DOI":"10.1016\/S0021-9258(17)39154-8","article-title":"Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation","volume":"260","author":"Shattil","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.thromres.2023.01.012_bb0100","series-title":"Biomarkers and Venous Thromboembolism. Arterioscler Thromb Vasc Biol [Internet]","first-page":"332","volume":"29","author":"Pabinger","year":"2009"},{"key":"10.1016\/j.thromres.2023.01.012_bb0105","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2141.2004.05032.x","article-title":"P-selectin in haemostasis: review","volume":"126","author":"Andr\u00e9","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2023.01.012_bb0110","doi-asserted-by":"crossref","first-page":"13835","DOI":"10.1073\/pnas.250475997","article-title":"Pro-coagulant state resulting from high levels of soluble P-selectin in blood","volume":"97","author":"Andr\u00e9","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.thromres.2023.01.012_bb0115","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1182\/blood-2008-02-142422","article-title":"High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)","volume":"112","author":"Ay","year":"2008","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2023.01.012_bb0120","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1373\/clinchem.2006.085068","article-title":"High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant","volume":"53","author":"Ay","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.thromres.2023.01.012_bb0125","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1182\/blood-2015-02-628461","article-title":"Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP","volume":"126","author":"Frelinger","year":"2015","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2023.01.012_bb0130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1160\/TH17-06-0387","article-title":"Platelet function in ITP, independent of platelet count, is consistent over time and is associated with both current and subsequent bleeding severity","volume":"118","author":"Frelinger","year":"2018","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.01.012_bb0135","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1182\/blood-2006-11-057968","article-title":"Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist","volume":"109","author":"Jenkins","year":"2007","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2023.01.012_bb0140","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1182\/blood-2011-11-393900","article-title":"In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation","volume":"119","author":"Psaila","year":"2012","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2023.01.012_bb0145","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/j.1538-7836.2005.01663.x","article-title":"The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study","volume":"3","author":"Rodeghiero","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.01.012_bb0150","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1089\/bio.2018.0032","article-title":"Usage data and scientific impact of the prospectively established fluid bioresources at the hospital-based MedUni Wien Biobank","volume":"16","author":"Haslacher","year":"2018","journal-title":"Biopreserv. Biobanking"},{"key":"10.1016\/j.thromres.2023.01.012_bb0155","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1182\/blood-2012-07-442392","article-title":"Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group","volume":"121","author":"Rodeghiero","year":"2013","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2023.01.012_bb0160","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00277-005-0029-5","article-title":"Agonists-induced platelet activation varies considerably in healthy male individuals: studies by flow cytometry","volume":"85","author":"Panzer","year":"2006","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.thromres.2023.01.012_bb0165","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3109\/09537104.2015.1032919","article-title":"Investigation of platelet function and platelet disorders using flow cytometry","volume":"27","author":"Rubak","year":"2016","journal-title":"Platelets."},{"key":"10.1016\/j.thromres.2023.01.012_bb0170","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00277-005-0029-5","article-title":"Agonists-induced platelet activation varies considerably in healthy male individuals: studies by flow cytometry","volume":"85","author":"Panzer","year":"2006","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.thromres.2023.01.012_bb0175","unstructured":"Quantikine\u00ae ELISA Human P-Selectin\/CD62P Immunoassay (Cat. No DPSE00) User Manual. R&D Systems,Inc. Distributed by Bio-Techne Ltd, 19 Barton Lane, Abingdon Science Park, Abingdon OX14 3NB,UK. Info.emea@bio-techne.com."},{"key":"10.1016\/j.thromres.2023.01.012_bb0180","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1182\/blood-2011-11-393900","article-title":"In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation","volume":"119","author":"Psaila","year":"2012","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2023.01.012_bb0185","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00277-011-1249-5","article-title":"Platelet activation and function during eltrombopag treatment in immune thrombocytopenia","volume":"91","author":"Haselboeck","year":"2012","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.thromres.2023.01.012_bb0190","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/rth2.12193","article-title":"Platelet function testing at low platelet counts: When can you trust your analysis?","volume":"3","author":"Bokn\u00e4s","year":"2019","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.01.012_bb0195","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/bjh.16439","article-title":"Reevaluation of platelet function in chronic immune thrombocytopenia: impacts of platelet size, platelet-associated anti-\u03b1IIb\u03b23 antibodies and thrombopoietin receptor agonists","volume":"189","author":"Nishiura","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2023.01.012_bb0200","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1111\/j.1538-7836.2011.04506.x","article-title":"Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia","volume":"9","author":"Psaila","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.01.012_bb0205","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1080\/09537104.2017.1296566","article-title":"Evaluation of platelet function in thrombocytopenia","volume":"29","author":"Skipper","year":"2018","journal-title":"Platelets."},{"key":"10.1016\/j.thromres.2023.01.012_bb0210","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.3324\/haematol.2017.185165","article-title":"Impaired mitochondrial activity explains platelet dysfunction in thrombocytopenic cancer patients undergoing chemotherapy","volume":"103","author":"Baaten","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2023.01.012_bb0215","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2141.2004.05156.x","article-title":"Multiple platelet defects identified by flow cytometry at diagnosis in acute myeloid leukaemia: AML Platelet Function Analysed by Flow Cytometry","volume":"127","author":"Leinoe","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2023.01.012_bb0220","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1182\/blood.V74.2.594.594","article-title":"Flow cytometric analysis of megakaryocytes from patients with abnormal platelet counts","volume":"74","author":"Tomer","year":"1989","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2023.01.012_bb0225","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0145-2126(99)00184-8","article-title":"Erythroblastic and\/or megakaryocytic dysplasia in de novo acute myeloid leukemias M0-M5 show relation to myelodysplastic syndromes and delimit two main categories","volume":"24","author":"Lemez","year":"2000","journal-title":"Leuk. Res."},{"key":"10.1016\/j.thromres.2023.01.012_bb0230","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1160\/TH16-02-0123","article-title":"Decreased platelet reactivity in patients with cancer is associated with high risk of venous thromboembolism and poor prognosis","volume":"117","author":"Riedl","year":"2017","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.01.012_bb0235","doi-asserted-by":"crossref","first-page":"795624","DOI":"10.3389\/fcvm.2021.795624","article-title":"Adverse outcome in COVID-19 is associated with an aggravating hypo-responsive platelet phenotype","volume":"8","author":"Schrottmaier","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.thromres.2023.01.012_bb0240","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/09537104.2017.1394451","article-title":"Effect of thrombopoietin receptor agonists on markers of coagulation and P-selectin in patients with immune thrombocytopenia","volume":"30","author":"Garabet","year":"2019","journal-title":"Platelets."},{"key":"10.1016\/j.thromres.2023.01.012_bb0245","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3892\/etm.2016.3347","article-title":"Novel association of soluble intercellular adhesion molecule 1 and soluble P-selectin with the ABO blood group in a Chinese population","volume":"12","author":"Zhang","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.thromres.2023.01.012_bb0250","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1182\/bloodadvances.2020002452","article-title":"Association of ABO blood group with bleeding severity in patients with bleeding of unknown cause","volume":"4","author":"Mehic","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2023.01.012_bb0255","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1182\/blood-2018-06-855528","article-title":"Blood group alters platelet binding kinetics to von Willebrand factor and consequently platelet function","volume":"133","author":"Dunne","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2023.01.012_bb0260","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/jth.14227","article-title":"Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults","volume":"16","author":"Piel-Julian","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.01.012_bb0265","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ajh.24234","article-title":"Is ITP a thrombophilic disorder?","volume":"91","author":"Rodeghiero","year":"2016","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2023.01.012_bb0270","first-page":"65","article-title":"Diagnostic approach to platelet function disorders","volume":"38","author":"Hayward","year":"2008","journal-title":"Transfus. Apher. Sci. Off. J. World Apher. Assoc. Off. J. Eur. Soc. Haemapheresis"},{"key":"10.1016\/j.thromres.2023.01.012_bb0275","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/blood.V70.1.307.307","article-title":"Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry","volume":"70","author":"Shattil","year":"1987","journal-title":"Blood."},{"key":"10.1016\/j.thromres.2023.01.012_bb0280","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1080\/09537104.2018.1557614","article-title":"Arachidonic acid causes lysis of blood cells and ADP-dependent platelet activation responses in platelet function tests","volume":"30","author":"Ramstr\u00f6m","year":"2019","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2023.01.012_bb0285","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1182\/bloodadvances.2021006904","article-title":"GPVI expression is linked to platelet size, age, and reactivity","volume":"6","author":"Veninga","year":"2022","journal-title":"Blood Adv."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823000129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823000129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:50:26Z","timestamp":1758736226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384823000129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":57,"alternative-id":["S0049384823000129"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.01.012","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet function and soluble P-selectin in patients with primary immune thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}